Identification of a potent NAFLD drug candidate for controlling T2DM-mediated inflammation and secondary damage <i>in vitro</i> and <i>in vivo</i>.

Identification of a potent NAFLD drug candidate for controlling T2DM-mediated inflammation and secondary damage in vitro and in vivo.

Samsuzzaman, Md; Lee, Jae Hyuk; Moon, Hyejin; Lee, Jisue; Lee, Heaji; Lim, Yunsook; Park, Myoung Gyu; Kim, Hakwon; Kim, Sun Yeou.

Afiliação

Samsuzzaman M; College of Pharmacy, Gachon University, Incheon, South Korea.
Lee JH; College of Pharmacy, Gachon University, Incheon, South Korea.
Moon H; Department of Applied Chemistry and Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Seoul, Gyeonggi, South Korea.
Lee J; Department of Applied Chemistry and Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Seoul, Gyeonggi, South Korea.
Lee H; Department of Food and Nutrition, Kyung Hee University, Seoul, South Korea.
Lim Y; Department of Food and Nutrition, Kyung Hee University, Seoul, South Korea.
Park MG; MetaCen Therapeutics Company, Suwon, Gyeonggi, South Korea.
Kim H; Department of Applied Chemistry and Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Seoul, Gyeonggi, South Korea.
Kim SY; College of Pharmacy, Gachon University, Incheon, South Korea.